Logo image
Strategic Amyotrophic Lateral Sclerosis Australia–Systems Genomics Consortium (SALSA-SGC): cohort profile
Journal article   Open access   Peer reviewed

Strategic Amyotrophic Lateral Sclerosis Australia–Systems Genomics Consortium (SALSA-SGC): cohort profile

Anjali K Henders, Laura Ziser, Fleur C Garton, Lorel Adams, Karalyn Ernst, Sarah Furlong, Judith Anne Heads, Susan Heggie, Ruth Krasniqi, Madhura Bhadravathi Lokeshappa, …
BMJ open, Vol.16(6), e110906
2026
PMID: 42315356
pdf
Published2.82 MBDownloadView
Open Access CC BY V4.0

Abstract

Cohort Profile Genetics and Genomics
Purpose Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative motor neuron disease (MND) with heterogeneity in disease onset, progression and treatment response. The Strategic ALS Australia–Systems Genomics Consortium (SALSA-SGC) was established in recognition of the need for large data sets of clinical data matched with biological samples to enable and foster ALS research and better understanding of aetiology and biological mechanisms. SALSA-SGC brought together the major Australian MND clinics to set up sustainable infrastructure that could facilitate long-term human ALS research and clinical trials nationally and internationally.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

Metrics

1 Record Views
Logo image